CRL vs NRXPW · rev $4.02B vs rev $242.0K
Charles River Laboratories (CRL) versus NRx Pharmaceuticals Inc (NRXPW) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. CRL currently screens at market cap $7.78B.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
CRL currently screens at market cap $7.78B. NRXPW currently screens at market cap $714.6M.
Not investment advice. Open the CRL and NRXPW stock pages for the full models.
Not investment advice.